Emily Humphrey

Published as: Emily S. Humphrey

VIC, Australia · RMSANZ Member (Ordinary Membership) · FAFRM

Institution(s): AU

MM 1 - Metropolitan(Postcode: 2010)

Cancer rehabilitationGenetics and molecular biologyNeurorehabilitationEpidemiology and public health

Clinical Expertise (self-reported)

NeurorehabilitationMusculoskeletal rehabilitationCardiac & respiratory rehabilitationPain managementStroke rehabilitationRehabilitation of older adultsTrauma rehabilitationAmputation, prosthetics and orthoticsCancer rehabilitationParkinson's disease and movement disordersSpasticity management

Source: RMSANZ Member Survey 2025 (Chapter 3)

H-index

Publications

9,668

Citations

175.8

FWCI

Funding Awards

Clinical Trials

Publication Timeline

Click a bar to filter publications by year

Funding Awards (50)

Whole-genome landscape of pancreatic neuroendocrine tumours

Medical Research Council · 2017(MR/N005813/1)

Erratum: Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours

Medical Research Council · 2017(MR/N005813/1)

Genomic analyses identify molecular subtypes of pancreatic cancer

Medical Research Council · 2016(MR/N005813/1)

Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases

National Health and Medical Research Council · 2016(1058540)

Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases

National Health and Medical Research Council · 2016(1084621)

Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases

Cancer Institute NSW · 2016(10/RSA/1–28)

Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases

National Health and Medical Research Council · 2016(1054497)

Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases

National Health and Medical Research Council · 2016(1052963)

Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling

National Health and Medical Research Council · 2016(1037320)

Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling

National Health and Medical Research Council · 2016(1083896)

Identifiers & Metadata

Profile ID:A5048396769

ORCID:0000-0003-0173-6135

Alt. IDs:

A5063331956 A5005962105

Confidence:REVIEW

Collaborators:0

Verification:Round 2 SUSPICIOUS: Name matches in both database (Emily S. Humphrey) and ORCID (Emily Humphrey). Affiliations are in AU (Garvan Institute, UNSW Sydney, St Vincent's Hospital). However, the topics and works are entirely

Publications (11 shown of 11 total)

Whole-genome landscape of pancreatic neuroendocrine tumours

Nature · 2017 · 996 citations● Rehab-relevant

Erratum: Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours

Nature · 2017 · 16 citations● Rehab-relevant

Genomic analyses identify molecular subtypes of pancreatic cancer

Nature · 2016 · 3693 citations

Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases

Journal of Biological Chemistry · 2016 · 41 citations

Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling

Molecular & Cellular Proteomics · 2016 · 39 citations

Whole genomes redefine the mutational landscape of pancreatic cancer

Nature · 2015 · 2655 citations

The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling

Molecular Cancer · 2015 · 57 citations

Characterization of the Novel Broad-Spectrum Kinase Inhibitor CTx-0294885 As an Affinity Reagent for Mass Spectrometry-Based Kinome Profiling

Journal of Proteome Research · 2013 · 53 citations

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Nature · 2012 · 2102 citations

RON is not a prognostic marker for resectable pancreatic cancer

BMC Cancer · 2012 · 17 citations